News

BioSpace7h
‘We Don’t Believe This is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says ...
BioSpace6h
Southeast’s Life Sciences Scene Heats Up With Job, Business Growth
Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...
BioSpace6h
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in ...
BioSpace6h
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
Canada’s health agency says it has been “taking all necessary action safeguard the drug supply and ensure Canadians have ...
BioSpace5h
Exit Strategy: Biopharma Pros Look Outside Industry—and US
A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...
BioSpace7h
FDA Asks Pfizer/BioNTech, Moderna to Add Myocarditis Risk to COVID-19 Vaccines
The FDA gave Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the ...
BioSpace6h
11 Companies Hiring Manufacturing Professionals
Looking for a manufacturing job? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.
BioSpace21h
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...
BioSpace6h
How Target Product Profiles Guide the Industry Through Uncertain Times
In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head ...